Mains Answer Writing - 10 Feb, 2026
GS2
Science & Technology
10 marks
What are biosimilars? Discuss how the Biopharma Shakti initiative can help improve access to biological therapies in India.
Tips for your answer
- Start with clarity of concepts – Briefly define biologics and biosimilars in 2–3 lines to set context.
- Link policy to problem – Clearly show how Biopharma Shakti addresses cost, capacity, regulation, and skills gaps.
- Balance access and innovation – Conclude by highlighting affordability today and indigenous biologic innovation tomorrow.
More Challenges
View All- View Challenge
GS3
Science & Technology
1 Mar, 2026
Carbon Capture and Utilisation (CCU) is emerging as a key strategy for decarbonising hard-to-abate sectors in India. Explain the concept of CCU and examine its potential, challenges, and policy measures required for its large-scale adoption in India.
- View Challenge
GS3
Indian Polity
Yesterday
“Recent advances in HIV treatment have focused on targeting the viral capsid using long-acting drugs such as lenacapavir.”
Explain the significance of capsid-targeting therapies in controlling HIV infection. Also discuss the challenges of drug resistance and the role of combination therapy. - View Challenge
GS2
Indian Polity
27 Feb, 2026
The balance between transparency and privacy is a recurring constitutional challenge in India.
In the light of recent amendments to the RTI framework through the Digital Personal Data Protection law, examine whether the exemption of personal information undermines accountability of public authorities.
Master Answer Writingfor UPSC Mains
Join thousands of aspirants mastering answer writing with daily challenges, instant AI evaluation, and topper copies
